The Good: AMC Last year, AMC was ailing and there were rumors of bankruptcy, or even a buyout, swirling in the waters. Now, it’s a regular fixture of “The Good” and a constant source of fascination. The new king of so-called “meme stocks,” AMC is having another banner start to a week. The movie theater stock surged as much as 25% today following a week in which the stock rose 80%. It ended up around 14.8%, or $55 today, but its sustained boom is something to watch. The stock has rallied 2100% this year alone. AMC’s movement coincided with other meme stocks, as Gamestop, BlackBerry and Bed Bath and Beyond all seeing major gains. The Also Good: Biogen There are a lot of exciting stock developments this week, so we decided to celebrate two stocks in the green. Biogen shares spiked nearly 60% today after the FDA approved the company’s new Alzheimers drug. The good news, and the following jump, surprised Biogen and Biogen analysts. The ripple effect into other Alzheimers adjacent bio companies was also apparent as the entire sector rose. While the drug will not meet full approval for some time, it could represent a significant step forward for Alzheimers treatment, particularly reflecting the FDA’s willingness to approve drugs with broad application. Biogen announced that the full treatment schedule for the drug would cost $56,000 a year. The Ugly: Progressive Progressive stock dipped almost 4% today following a downgrade from Morgan Stanley. The stock was pushed down to underweight by analysts who cited looming margin pressure. With more people hitting the road post-pandemic, accident frequency is likely to increase. This, coupled with elevated car repair costs amidst a competitive car market, leads analysts to think will weigh on margins. Deteriorating margins may continue well into 2021. Additionally, the insurance company’s involvement with homeowners’ business will add to catastrophe risk.